Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Gugler

Showing results (131-140 of 154) with videos related to

Pageof 16
Sort By:
Klinische Wochenschrift|March 15, 1985
Serum-cholesterol-lowering effect of metronidazole and possible mechanisms of actionK von Bergmann, U Streicher, O Leiss, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 1, 1978
[Endoscopic diagnosis of hiatal hernias (axial and paraesophageal hernias)]H G Rohner, M Wienbeck, R Gugler, et al.
Gastroenterology|February 1, 1991
Is radical scavenging necessary in the treatment of inflammatory bowel disease?H Allgayer, R Gugler, P Böhme, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Influence of thyroid function on human drug metabolism]R Gugler, M Eichelbaum, C Schneider-Deters, et al.
The New England Journal of Medicine|May 9, 1974
Influence of thyroid status on plasma half-life of antipyrine in manM Eichelbaum, G Bodem, R Gugler, et al.
European Journal of Clinical Pharmacology|June 12, 1979
Clofibrate disposition in renal failure and acute and chronic liver diseaseR Gugler, J W Kürten, C J Jensen, et al.
Biochemical Pharmacology|January 22, 1992
Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Direct evaluation with electron spin resonance spectroscopyH Allgayer, P Höfer, M Schmidt, et al.
Klinische Wochenschrift|November 15, 1985
Factors predicting the therapeutic outcome of duodenal ulcer treatment with H2-receptor antagonistsR Gugler, J C Jensen, H G Rohner, et al.
Journal of Viral Hepatitis|January 24, 2004
Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infectionS Engler, C Flechtenmacher, K H Wiedemann, et al.
Arzneimittel-Forschung|January 1, 1976
Proceedings: Pharmacokinetics of drugs in patients with nephrotic syndromeD L Azarnoff, R Gugler, D W Shoeman, et al.
Pageof 16

Showing results (131-140 of 154) with videos related to

Sort By:
Pageof 16
Klinische Wochenschrift|March 15, 1985
Serum-cholesterol-lowering effect of metronidazole and possible mechanisms of actionK von Bergmann, U Streicher, O Leiss, et al.
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|July 1, 1978
[Endoscopic diagnosis of hiatal hernias (axial and paraesophageal hernias)]H G Rohner, M Wienbeck, R Gugler, et al.
Gastroenterology|February 1, 1991
Is radical scavenging necessary in the treatment of inflammatory bowel disease?H Allgayer, R Gugler, P Böhme, et al.
Verhandlungen Der Deutschen Gesellschaft Fur Innere Medizin|January 1, 1973
[Influence of thyroid function on human drug metabolism]R Gugler, M Eichelbaum, C Schneider-Deters, et al.
The New England Journal of Medicine|May 9, 1974
Influence of thyroid status on plasma half-life of antipyrine in manM Eichelbaum, G Bodem, R Gugler, et al.
European Journal of Clinical Pharmacology|June 12, 1979
Clofibrate disposition in renal failure and acute and chronic liver diseaseR Gugler, J W Kürten, C J Jensen, et al.
Biochemical Pharmacology|January 22, 1992
Superoxide, hydroxyl and fatty acid radical scavenging by aminosalicylates. Direct evaluation with electron spin resonance spectroscopyH Allgayer, P Höfer, M Schmidt, et al.
Klinische Wochenschrift|November 15, 1985
Factors predicting the therapeutic outcome of duodenal ulcer treatment with H2-receptor antagonistsR Gugler, J C Jensen, H G Rohner, et al.
Journal of Viral Hepatitis|January 24, 2004
Interferon alfa2a induction therapy in combination with ribavirin and amantadine for the treatment of naive patients with chronic HCV infectionS Engler, C Flechtenmacher, K H Wiedemann, et al.
Arzneimittel-Forschung|January 1, 1976
Proceedings: Pharmacokinetics of drugs in patients with nephrotic syndromeD L Azarnoff, R Gugler, D W Shoeman, et al.
Pageof 16